Currently, there are 271.70M common shares owned by the public and among those 262.38M shares have been available to trade.
The company’s stock has a 5-day price change of -0.91% and -13.99% over the past three months. OVV shares are trading -8.17% year to date (YTD), with the 12-month market performance down to -15.22% lower. It has a 12-month low price of $36.90 and touched a high of $55.95 over the same period. OVV has an average intraday trading volume of 3.03 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 1.74%, -4.02%, and -12.73% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Ovintiv Inc (NYSE: OVV) shares accounts for 81.10% of the company’s 271.70M shares outstanding.
It has a market capitalization of $10.63B and a beta (3y monthly) value of 2.64. The stock’s trailing 12-month PE ratio is 5.69, while the earnings-per-share (ttm) stands at $7.09. The company has a PEG of 0.63 and a Quick Ratio of 0.44 with the debt-to-equity ratio at 0.68. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.28% over the week and 3.16% over the month.
Earnings per share for the fiscal year are expected to decrease by -23.92%, and 2.01% over the next financial year. EPS should grow at an annualized rate of 9.00% over the next five years, compared to 7.25% over the past 5-year period.
Looking at the support for the OVV, a number of firms have released research notes about the stock. Wolfe Research stated their Outperform rating for the stock in a research note on July 18, 2024, with the firm’s price target at $65. Evercore ISI coverage for the Ovintiv Inc (OVV) stock in a research note released on June 14, 2024 offered a Outperform rating with a price target of $60. Barclays was of a view on April 10, 2024 that the stock is Overweight, while JP Morgan gave the stock Overweight rating on December 06, 2023, issuing a price target of $61- $58. Citigroup on their part issued Buy rating on November 22, 2023.
